Jennifer Linehan is a board-certified urologist, and is an associate professor of urology and urologic oncology at the Saint John’s Cancer Institute. She also practices general urology, including both male and female voiding dysfunction and treatment for kidney stones.
Dr. Linehan completed her medical degree at the College of Medicine at the University of Arizona. She subsequently completed a general surgery internship and then urology residency at the University of Arizona where she received the George M. Drach Award for the most compassionate urologic resident. At the time, she also received awards for research in diagnosis and management of kidney cancer. She joined City of Hope in 2010 as a fellow in robotic and urologic oncology then joined the staff in the City of Hope Medical Group. She is an experienced robotic and laparoscopic surgeon who also has interest in endoscopy for both ureteral cancers and ureteral stones.
Dr. Linehan, above all else is committed to helping patients by focusing on individual patient care, comfort and education. She works hard to provide personalized service and hope to focus on the patient as a whole. She is dedicated to comprehensive cancer care working with a full multidisciplinary team, including medical and radiation oncologists.
In addition, Dr. Linehan has been involved in prostate cancer research. She has worked closely with Steven Smith, Ph.D., at Beckman Research Institute of City of Hope on identifying biomarkers for prostate cancer. She has authored papers, presented abstracts and research at conferences across the world and continues to dedicate time to both basic science and clinical research.
Dr. Linehan is certified by the American Board of Urology and is a member of the Society of Urologic Oncology, American Urologic Association and the Western Section Urologic Association. She has a lifelong love of animals, particularly involvement with rescue dogs and dedicates time weekly to help educate less fortunate families and children.
Current Treatment Options and Future Treatment Options: Addressing the Unmet Needs in Treating UTUC
Upper Tract Urothelial Carcinomas | Part II: Treatment Options